Gregory J Riely Selected Research

Transaminases (Aminotransferases)

1/2018	Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial.
3/2014	Ceritinib in ALK-rearranged non-small-cell lung cancer.
6/2013	Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregory J Riely Research Topics

Disease

98	Neoplasms (Cancer) 03/2024 - 03/2005
76	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 02/2006
75	Lung Neoplasms (Lung Cancer) 02/2024 - 03/2005
41	Adenocarcinoma of Lung 01/2023 - 01/2005
16	Disease Progression 01/2023 - 02/2006
11	Thymoma (Thymic Carcinoma) 01/2022 - 02/2008
10	Neoplasm Metastasis (Metastasis) 01/2024 - 09/2014
9	Brain Neoplasms (Brain Tumor) 12/2023 - 02/2012
8	Adenocarcinoma 06/2014 - 01/2005
6	Fatigue 02/2024 - 04/2011
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2022 - 02/2011
4	Melanoma (Melanoma, Malignant) 02/2024 - 07/2012
4	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2019 - 02/2011
3	Diarrhea 02/2024 - 03/2014
3	Carcinogenesis 01/2022 - 02/2012
3	Exanthema (Rash) 01/2020 - 04/2011
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2016 - 02/2012
3	Neutropenia 09/2014 - 02/2007
2	Nausea 02/2024 - 01/2018
2	Vomiting 02/2024 - 03/2014
2	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 01/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2023 - 10/2005
2	COVID-19 08/2023 - 01/2023
2	Carcinoma (Carcinomatosis) 10/2022 - 06/2014
2	Hemorrhage 01/2022 - 02/2011
2	Dyspnea (Shortness of Breath) 10/2018 - 06/2013
2	Pain (Aches) 01/2018 - 02/2014
2	Sarcoma (Soft Tissue Sarcoma) 12/2012 - 02/2012
2	Thymus Neoplasms (Thymus Neoplasm) 01/2012 - 12/2011
2	Hypersensitivity (Allergy) 11/2011 - 02/2008
1	Skin Neoplasms (Skin Cancer) 02/2024
1	Mesothelioma 01/2024
1	Residual Neoplasm 09/2023

Drug/Important Bio-Agent (IBA)

52	ErbB Receptors (EGF Receptor)IBA 01/2023 - 01/2005
46	Tyrosine Kinase InhibitorsIBA 09/2023 - 03/2005
31	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 01/2005
23	Gefitinib (Iressa)FDA Link 05/2015 - 01/2005
16	CrizotinibIBA 01/2020 - 10/2011
11	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2011
9	DNA (Deoxyribonucleic Acid)IBA 02/2024 - 11/2008
9	Anaplastic Lymphoma KinaseIBA 01/2019 - 02/2012
8	osimertinibIBA 12/2023 - 10/2017
8	PlatinumIBA 11/2023 - 02/2007
8	Phosphotransferases (Kinase)IBA 01/2018 - 01/2005
7	B7-H1 AntigenIBA 11/2023 - 10/2017
7	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023 - 07/2012
6	GenieIBA 01/2024 - 02/2022
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2010
5	Immune Checkpoint InhibitorsIBA 11/2023 - 01/2018
5	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 10/2015 - 02/2006
4	mobocertinibIBA 01/2023 - 01/2021
4	Circulating Tumor DNAIBA 11/2022 - 03/2016
4	Codon (Codons)IBA 01/2021 - 09/2008
4	Bevacizumab (Avastin)FDA Link 01/2020 - 02/2011
4	alectinibIBA 01/2018 - 09/2014
3	binimetinibIBA 02/2024 - 03/2022
3	encorafenibIBA 02/2024 - 03/2022
3	Oxygen (Dioxygen)IBA 08/2023 - 02/2020
3	adagrasibIBA 01/2023 - 01/2021
3	trametinibIBA 01/2022 - 01/2020
3	human ERBB2 proteinIBA 12/2019 - 02/2012
3	lorlatinibIBA 12/2019 - 12/2018
3	cabozantinibIBA 10/2018 - 01/2016
3	Transaminases (Aminotransferases)IBA 01/2018 - 06/2013
3	ceritinibIBA 01/2017 - 03/2014
3	Paclitaxel (Taxol)FDA LinkGeneric 11/2011 - 02/2008
3	Everolimus FDA Link 10/2010 - 08/2007
3	Threonine (L-Threonine)FDA Link 11/2008 - 03/2005
2	sotorasibIBA 01/2023 - 01/2021
2	dacomitinibIBA 01/2023 - 01/2021
2	ChromatinIBA 11/2022 - 01/2022
2	NivolumabIBA 10/2022 - 10/2017
2	atezolizumabIBA 10/2022 - 10/2017
2	Sunitinib (Sutent)FDA Link 01/2022 - 10/2018
2	hydroxide ionIBA 01/2021 - 10/2020
2	pembrolizumabIBA 10/2020 - 10/2017
2	cyclo(Arg-Pro) (CI 4)IBA 01/2020 - 05/2011
2	Cell-Free Nucleic AcidsIBA 12/2019 - 11/2019
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2018 - 11/2014
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2018 - 02/2008
2	Alanine Transaminase (SGPT)IBA 01/2018 - 10/2012
2	SolventsIBA 01/2016 - 11/2011
2	AfatinibIBA 05/2015 - 09/2014
2	Temozolomide (Temodar)FDA LinkGeneric 11/2014 - 02/2012
2	MethyltransferasesIBA 11/2014 - 02/2012
2	Cetuximab (Erbitux)FDA Link 09/2014 - 04/2011
2	MucinsIBA 08/2014 - 02/2011
2	Albumin-Bound Paclitaxel FDA Link 11/2011 - 02/2008
2	AlbuminsIBA 11/2011 - 02/2008
2	Colloids (Colloid)IBA 05/2011 - 02/2011
2	Methionine (L-Methionine)FDA Link 11/2006 - 03/2005

Therapy/Procedure

87	Therapeutics 03/2024 - 03/2005
20	Drug Therapy (Chemotherapy) 11/2023 - 10/2005
10	Immunotherapy 01/2023 - 01/2016
6	Radiotherapy 01/2023 - 01/2012
5	Aftercare (After-Treatment) 01/2021 - 03/2008
2	Artificial Respiration (Mechanical Ventilation) 08/2023 - 01/2023
2	Palliative Care (Palliative Therapy) 01/2015 - 01/2012
2	Adjuvant Chemotherapy 08/2013 - 04/2009
2	Premedication 11/2011 - 02/2008